1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow 4E Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Safety, Tolerability and Exposure of 4ET1103 in Healthy Human Volunteers LY4286533, placebo - Neuropathic Pain | Phase 1 | Completed | 4E Therapeutics | 40 | 2025-04-18 | 2026-09-08 |
Neuralgia (1)
United States (1)
U44NS115692 (1)